Pressure BioSciences, Inc.
US ˙ OTCPK ˙ US74112E2081

Introduction

This page provides a comprehensive analysis of the known insider trading history of Kevin Pollack. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Kevin Pollack has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:PBIO / Pressure BioSciences, Inc. Director 36,787
US:TRNF / Taronis Fuels Inc Director 33,875
US:TRNX / BBHC Inc Director 525,583
US:OPNT / Opiant Pharmaceuticals Inc See Remarks, Director 4,820
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Kevin Pollack. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PBIO / Pressure BioSciences, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PBIO / Pressure BioSciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2013-08-30 PBIO Pollack Kevin 7,500 0.2780 250 8.3400 2,085 201 0.7 -1,910 -91.61
2013-08-21 PBIO Pollack Kevin 7,500 0.2780 250 8.3400 2,085
2013-08-21 PBIO Pollack Kevin 2,500 0.2739 83 8.2170 685

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PBIO / Pressure BioSciences, Inc. Insider Trades
Insider Sales PBIO / Pressure BioSciences, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PBIO / Pressure BioSciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PBIO / Pressure BioSciences, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Kevin Pollack as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-03-28 2024-03-27 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 2,914 36,787 8.60 0.16 466 5,886
2023-12-08 2023-12-06 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 5,294 33,873 18.52 0.36 1,906 12,194
2023-10-24 2023-10-20 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 1,725 28,553 6.43 0.63 1,087 17,988
2023-05-31 2023-05-26 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 808 26,828 3.11 0.87 703 23,340
2023-03-28 2023-03-24 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 848 26,020 3.37 1.39 1,179 36,168
2022-12-09 2022-12-08 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 771 25,172 3.16 1.24 956 31,213
2022-08-02 2022-07-29 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 609 24,401 2.56 1.69 1,029 41,238
2022-06-28 2022-06-24 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 539 23,792 2.32 1.91 1,029 45,443
2022-05-03 2022-04-29 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 465 23,253 2.04 2.21 1,028 51,389
2022-03-02 2022-02-28 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 409 22,788 1.83 2.51 1,027 57,198
2021-11-16 2021-11-12 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 482 22,379 2.20 2.13 1,027 47,667
2021-06-01 2021-05-28 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 494 21,897 2.31 2.08 1,028 45,546
2021-04-23 2021-04-22 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 498 21,403 2.38 2.06 1,026 44,090
2021-01-08 2021-01-07 4 TRNF Taronis Fuels, Inc.
Stock Option (Right to Buy)
A - Award 33,875 33,875
2020-12-11 2020-12-10 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 662 20,905 3.27 1.55 1,026 32,403
2020-08-31 2020-08-28 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 443 20,243 2.24 2.32 1,028 46,964
2020-06-10 2020-06-08 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 490 19,800 2.54 2.45 1,200 48,510
2020-05-01 2020-04-29 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 742 19,310 4.00 1.34 994 25,875
2020-04-01 2020-03-30 4 TRNF Taronis Fuels, Inc.
Common stock, par value $0.001 per share
P - Purchase 108,696 2,736,611 4.14 0.09 10,000 251,768
2019-12-27 2019-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 52,806 52,806
2019-12-27 2019-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 17,602 17,602
2019-12-27 2019-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -17,602 0 -100.00
2019-12-10 2019-12-06 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 379 18,947 2.04 2.77 1,050 52,483
2019-11-25 2019-11-21 4 TRNX TARONIS TECHNOLOGIES, INC.
Common stock, par value $0.001 per share
A - Award 384,507 525,583 272.55 1.74 669,042 914,514
2019-10-09 2019-10-07 4/A TRNX TARONIS TECHNOLOGIES, INC.
Common stock, par value $0.001 per share
A - Award 88,719 141,076 169.45 1.72 152,597 242,651
2019-10-08 2019-10-07 4 TRNX TARONIS TECHNOLOGIES, INC.
Common stock, par value $0.001 per share
A - Award 88,719 122,132 265.52 1.72 152,597 210,067
2019-08-21 2019-08-19 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 367 18,568 2.02 2.83 1,039 52,547
2019-08-15 2019-08-14 4 TRNX TARONIS TECHNOLOGIES, INC.
Common stock, par value $0.001 per share
A - Award 93,750 260,814 56.12 0.80 75,000 208,651
2019-07-01 2019-06-28 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 322 18,201 1.80 3.19 1,027 58,045
2019-07-01 2019-06-28 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 517 17,879 2.98 2.03 1,050 36,294
2019-04-03 2019-04-01 4 TRNX TARONIS TECHNOLOGIES, INC.
Common stock, par value $0.001 per share
A - Award 166,667 166,731 260,417.19 0.63 105,000 105,041
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 14,268
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 4,500 14,268 46.07
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -4,500 0 -100.00
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -4,500 0 -100.00
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 3,600 9,768 58.37
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -3,600 0 -100.00
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 834 6,168 15.64
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -834 0 -100.00
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -834 0 -100.00
2018-12-21 2018-12-19 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 834 5,334 18.53
2018-11-28 2018-11-27 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 345 17,362 2.03 3.67 1,266 63,719
2018-09-19 2018-09-19 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 310 17,017 1.86 3.27 1,014 55,646
2018-09-19 2018-09-18 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 316 16,707 1.93 4.01 1,267 66,995
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 4,500 8,100 125.00
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 4,500 8,100 125.00
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -4,500 0 -100.00
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 3,600 3,600
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -3,600 0 -100.00
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 3,334 3,334
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -3,334 0 -100.00
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 834 1,668 100.00
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 834 1,668 100.00
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -834 0 -100.00
2018-07-20 2018-07-18 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
D - Sale to Issuer -834 0 -100.00
2018-06-13 2018-06-11 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK WARRANT
J - Other 2,778 2,778
2018-06-13 2018-06-11 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK WARRANT
J - Other 20,500 20,500
2018-06-13 2018-06-11 4 PBIO PRESSURE BIOSCIENCES INC
SERIES AA CONVERTIBLE PREFERRED STOCK
J - Other 20 20 2,500.00 51,250 51,250
2018-04-23 2018-04-20 4 MNGA MAGNEGAS CORP
Common stock, par value $0.001 per share
A - Award 11,004 19,792 125.22 0.78 8,583 15,437
2018-03-28 2018-03-27 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 390 16,391 2.44 3.32 1,295 54,418
2018-03-16 2018-03-14 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 309 16,001 1.97 4.19 1,295 67,044
2017-12-18 2017-12-15 4 MNGA MAGNEGAS CORP
Common stock, par value $0.001 per share
P - Purchase 108,334 131,813 461.41 0.29 31,417 38,226
2017-11-27 2017-11-22 4 PBIO PRESSURE BIOSCIENCES INC
COMMON STOCK
J - Other 181 15,692 1.17 7.66 1,386 120,201
2017-03-21 2017-03-16 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Options
A - Award 135,000 135,000
2017-01-17 2017-01-13 4 OPNT OPIANT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 4,820 4,820 6.98 33,644 33,644
2016-12-06 2016-12-06 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
P - Purchase 21,400 234,795 10.03 0.47 10,058 110,354
2016-12-06 2016-12-02 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
P - Purchase 21,800 213,395 11.38 0.46 10,028 98,162
2016-09-14 2016-09-13 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 64,516 191,595 50.77 0.62 40,000 118,789
2016-01-05 2015-12-31 4 PBIO PRESSURE BIOSCIENCES INC
21 Month Common Stock Purchase Warrant
A - Award 50,000 50,000
2016-01-05 2015-12-31 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Options
A - Award 108,000 108,000
2015-10-30 2015-10-27 4 LLTP Lightlake Therapeutics Inc.
Options
A - Award 500,000 1,580,000 46.30
2015-10-30 2014-06-15 4 LLTP Lightlake Therapeutics Inc.
Options
A - Award 200,000 1,080,000 22.73
2015-10-30 2014-06-15 4 LLTP Lightlake Therapeutics Inc.
Options
A - Award 150,000 880,000 20.55
2015-10-30 2013-12-31 4 LLTP Lightlake Therapeutics Inc.
Options
A - Award 75,000 730,000 11.45
2015-10-30 2013-08-01 4 LLTP Lightlake Therapeutics Inc.
Options
A - Award 50,000 655,000 8.26
2015-10-30 2013-08-01 4 LLTP Lightlake Therapeutics Inc.
Options
A - Award 50,000 655,000 8.26
2015-10-30 2013-05-01 4 LLTP Lightlake Therapeutics Inc.
Options
A - Award 165,000 555,000 42.31
2015-10-30 2013-05-01 4 LLTP Lightlake Therapeutics Inc.
Options
A - Award 190,000 390,000 95.00
2015-07-06 2015-07-02 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 12,107 127,079 10.53 0.83 10,000 104,967
2015-03-25 2015-03-20 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 13,947 114,972 13.81 0.72 10,042 82,780
2014-12-23 2014-12-22 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock Warrant
A - Award 40,000 40,000
2014-12-23 2014-12-22 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock Warrant
M - Exercise -40,000 0 -100.00
2014-12-23 2014-12-22 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
J - Other 40,000 57,500 228.57 0.25 10,000 14,375
2014-12-02 2014-11-26 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 12,107 101,025 13.62 0.83 10,049 83,851
2014-11-14 2014-11-12 4 PBIO PRESSURE BIOSCIENCES INC
Series K Convertible Preferred Stock
P - Purchase 20 20
2014-11-14 2014-11-12 4 PBIO PRESSURE BIOSCIENCES INC
Series K Common Stock Purchase Warrant
P - Purchase 20 20
2014-09-26 2014-09-24 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 100,000 100,000
2014-08-21 2014-08-20 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 8,554 88,918 10.64 1.17 10,008 104,034
2014-05-29 2014-05-28 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 7,837 80,364 10.81 1.27 9,953 102,062
2014-04-08 2014-04-07 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 12,048 72,527 19.92 0.83 10,000 60,197
2014-04-08 2014-04-07 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 15,723 60,479 35.13 0.63 9,905 38,102
2014-01-30 2014-01-30 4 PBIO PRESSURE BIOSCIENCES INC
Series K Common Stock Purchase Warrant
P - Purchase 45,000 45,000
2014-01-30 2014-01-30 4 PBIO PRESSURE BIOSCIENCES INC
Series K Convertible Preferred Stock
P - Purchase 90 90,000 0.10
2013-12-19 2013-09-27 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 13,245 44,756 42.03 0.76 10,066 34,015
2013-12-19 2013-06-17 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 7,092 31,511 29.04 1.41 10,000 44,431
2013-12-19 2013-02-27 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 3,226 24,419 15.22 1.55 5,000 37,849
2013-12-19 2013-02-27 4 MNGA MAGNEGAS CORP
Common Stock, par value $0.001 per share
A - Award 14,493 21,193 216.31 1.38 20,000 29,246
2013-12-16 2013-12-12 4 PBIO PRESSURE BIOSCIENCES INC
Series K Common Stock Purchase Warrant
P - Purchase 45,000 45,000
2013-12-16 2013-12-12 4 PBIO PRESSURE BIOSCIENCES INC
Series K Convertible Preferred Stock
P - Purchase 90 90,000 0.10
2013-09-04 2013-08-30 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
P - Purchase 7,500 17,500 75.00 0.28 2,085 4,865
2013-08-23 2013-08-21 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
P - Purchase 2,500 10,000 33.33 0.27 685 2,739
2013-08-23 2013-08-21 4 PBIO PRESSURE BIOSCIENCES INC
Common Stock
P - Purchase 7,500 10,000 300.00 0.28 2,085 2,780
2013-02-13 2013-02-06 4 PBIO PRESSURE BIOSCIENCES INC
Series J Common Stock Warrant
P - Purchase 110,793 269,586 69.77
2013-02-13 2013-02-06 4 PBIO PRESSURE BIOSCIENCES INC
Series J Convertible Preferred Stock
P - Purchase 111 158,793 0.07
2013-01-03 2012-12-31 4 LLTP Lightlake Therapeutics Inc.
Common Stock Warrants
A - Award 5,500,000 20,000,000 37.93
2013-01-03 2012-12-31 4 LLTP Lightlake Therapeutics Inc.
Common Stock Options (right to buy)
A - Award 6,500,000 14,500,000 81.25
2013-01-03 2012-12-31 4 LLTP Lightlake Therapeutics Inc.
Common Stock Options (right to buy)
A - Award 2,500,000 8,000,000 45.45
2012-10-11 2012-09-25 4 MNGA MAGNEGAS CORP
Common stock, par value $0.001 per share
A - Award 6,700 6,700
2012-07-10 2012-07-06 4 PBIO PRESSURE BIOSCIENCES INC
Series G Common Stock Purchase Warrant
P - Purchase 40,000 40,000
2012-07-10 2012-07-06 4 PBIO PRESSURE BIOSCIENCES INC
Series G Convertible Preferred Stock
P - Purchase 8,000 8,000
2012-07-06 2012-07-03 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Options
A - Award 25,000 25,000
2012-07-06 2012-07-03 4 PBIO PRESSURE BIOSCIENCES INC
Non-Qualified Stock Options
A - Award 25,000 25,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)